Silvia Sapino

Mrs. Silvia Sapino

University of Turin

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
GRGiuseppe Riva
Giuseppe Riva
SSSilvia Sapino
Silvia Sapino
MRMattia Ravera
Mattia Ravera
GEGiulia Elia
Giulia Elia
Giancarlo PecorariGiancarlo Pecorari
Giancarlo Pecorari
Partial glossectomy and reconstruction strategy for malignant tongue tumors influences speech and swallowing. The aim of this retrospective study was to evaluate long-term functional outcomes after partial glossectomy for pT2 mobile tongue carcinomas with a maximum dimension between 2 and 3cm. Different reconstruction strategies (with or without pedicled flap) were compared. Twenty-two patients with at least 12 months followup were included. Clinician-based and self-reported instruments were used to analyze tongue motility, speech intelligibility and articulation, swallowing, and quality of life. Patients with a higher tongue motility had better articulation and lower dysphagia. Avoiding pedicled flap reconstruction seemed to guarantee lower impairment of speech and swallowing. Worse functional outcomes induced a lower quality of life. Partial glossectomy results in tongue motility impairment and consequently alterations of oral functions. Since the type of reconstruction impacts long-term outcomes, it should be adequately planned before surgery.

30 August 2022 in Otology & Neurotology
Verified
Journal Article
Closed access
ACAndrea Canale
Andrea Canale
DNDrita Ndrev
Drita Ndrev
SSSilvia Sapino
Silvia Sapino
CBCarlotta Bianchi
Carlotta Bianchi
VBvalerio bordino
valerio bordino
AAAndrea Albera
Andrea Albera
Objective: To evaluate speech in noise results and subjective benefit in bilateral active bone conduction implant (ABCI) for bilateral mixed hearing loss. Study Design: Prospective, comparative. Setting: Ear, Nose and Throat Unit, Department of Surgical Sciences, University of Turin. Patients: Seven patients with conductive/mixed hearing loss. Intervention(s): Patients underwent simultaneous or sequential bilateral surgery for ABCI. Main Outcome Measure(s): The speech intelligibility in noise was assessed with the Ita Matrix test in summation, squelch and head shadow settings. First, the tests were performed with one device activated in the ear with lower speech recognition score, then with both devices. Patients filled in an Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire to investigate the hearing aid benefit. Results: When bilateral devices were activated, an improvement of signal-to-noise ratio was observed in all settings. The difference between bilateral and unilateral stimulation is 4.66 dB (p = 0.016) in the summation, 2.24 dB (p = 0.047) in the squelch, 7.50 dB (p = 0.016) in the head shadow setting. Looking at the APHAB global score (GS), patients report lower mean scores, hence less difficulties, when using two devices (GS, 21.9%; standard deviation (SD), 8.28) rather than one (GS, 33.0%; SD, 10.24) (p = 0.018). Conclusion: In symmetric mixed bilateral hearing loss, rehabilitation with an ABCI fitted bilaterally shows audiologic advantages in speech perception in noise, not only thanks to the summation effect and by reducing head shadow but also by improving the binaural unmasking based on the squelch effect. Audiometric outcomes are confirmed by the GSs obtained in the APHAB questionnaire.

24 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GRGiuseppe Riva
Giuseppe Riva
LSLaura Salonia
Laura Salonia
EFElisabetta Fassone
Elisabetta Fassone
SSSilvia Sapino
Silvia Sapino
FPFabrizio Piano
Fabrizio Piano
Giancarlo PecorariGiancarlo Pecorari
Giancarlo Pecorari
Background: Primary or recurrent head and neck cancer of skin or mucosa represents a challenge for clinicians and could be debilitating for the patient. Electrochemotherapy (ECT) emerged as a local ablative procedure for cutaneous and mucosal head and neck tumors. The aim of this observational study was the evaluation of quality of life (QoL) after ECT in patients without other surgical or radiation options as curative treatment. Materials and methods: The procedure was performed according the ESOPE (European Standard Operating procedure of Electrochemotherapy) protocol. Twenty-seven patients were evaluated before ECT (T0) and 1 (T1), 3 (T2), and 6 (T3) months after the procedure. QoL was assessed by means of the EORTC QLQ-C30 and EORTC QLQ-H&N35 questionnaires. Results: The objective tumor response rate was 48% (11% CR, 37% PR). Bleeding control was achieved in 7/7 patients who experienced bleeding prior to ECT. QoL improvement was observed after the procedure. In particular, global health status and social functioning were higher after ECT (p 0.026 and 0.043), while pain, pain-killers use and appetite loss decreased (p 0.045, 0.025 and 0.002). Conclusion: ECT represents a safe and effective treatment for skin and mucosal head and neck tumors without other curative options. It ensures a good pain and bleeding control without worsening of QoL.